(PRESS RELEASE)_MIAMI, FL. - July 21, 2022 - In response to the conclusion of the CDC’s voluntary program, Virgin Voyages will continue to consider the recommendations set forth by the organization, while also adhering to the industry policies outlined by CLIA. As a result of this update, Virgin Voyages will remove the requirements for pre-embarkation testing.
Virgin Voyages has responded immediately to the CDC’s decision to discontinue their voluntary COVID-19 Program for Cruise Ships and will mirror the rest of the travel industry in removing pre-embarkation testing for sailings from July 24 on EU sailings, and from July 27 on US sailings. Vaccine requirements will remain in place for both Scarlet Lady, operating out of the US, and Valiant Lady in the EU. Virgin Voyages is currently evaluating this policy and will announce further updates in the near future.
Passenger and crew well-being is the major focus and they continue to follow the advice of their expert medical team. To clarify these updates:
Other well-being measures implemented during the pandemic, including enhanced air purification systems and deep cleaning/sanitization will be maintained. Virgin Voyages will continue to work closely with the CDC and collaborate with the industry to implement all appropriate measures. Along with the rest of the cruise industry, the brand welcomes the update and autonomy that has been afforded the rest of the travel sector over the past several years. The news comes as the cruise industry continues to regain post-pandemic momentum.
For more information on Virgin Voyages' health and safety updates, visit the Voyage Well page here.
Stay current with the latest news from the cruise lines.
Follow Gerry Barker
on All Things Cruise.
Follow Gerry on Splash Magazines Worldwide